U.S., Jan. 13 -- ClinicalTrials.gov registry received information related to the study (NCT07333885) titled 'Impact of Reducose(R) on Glycemic Response and Menopausal Symptoms in Perimenopausal Women (CALM-R)' on Dec. 19, 2025.
Brief Summary: The purpose of this double-blind, randomized, placebo-controlled trial is to. evaluate daily Reducose(R) (mulberry leaf extract) supplementation taken with the two largest meals for 12 weeks on improving glycemic response and perimenopausal symptoms in women aged 40-60 years. Glycemic response is measured using Dexcom Stelo continuous glucose monitors during standardized test meals, and menopausal symptoms and sleep/quality-of-life outcomes are assessed using validated surveys administered through the...